beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors
about
A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expressionHeterodimerization of alpha 2A- and beta 1-adrenergic receptorsSelectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteinsBeta-2 adrenergic receptor mediated ERK activation is regulated by interaction with MAGI-3Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activationGIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activationG protein-coupled receptor kinase 5 regulates beta 1-adrenergic receptor association with PSD-95Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathwayLigand binding of the second PDZ domain regulates clustering of PSD-95 with the Kv1.4 potassium channelPhosphorylation of stargazin by protein kinase A regulates its interaction with PSD-95Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rateVangl2, the planar cell polarity protein, is complexed with postsynaptic density protein PSD-95 [corrected]AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta1-adrenergic receptor promotes recycling and functional resensitization of the receptorUbiquitination regulates PSD-95 degradation and AMPA receptor surface expressionPDZ domain proteins of synapsesFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.SAP97 controls the trafficking and resensitization of the beta-1-adrenergic receptor through its PDZ2 and I3 domainsRegulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling.A long lasting β1 adrenergic receptor stimulation of cAMP/protein kinase A (PKA) signal in cardiac myocytes.Viagra for your synapses: Enhancement of hippocampal long-term potentiation by activation of beta-adrenergic receptors.Ligand-directed signalling at beta-adrenoceptorsbeta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation.Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97.Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortexMAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.PDZ domain-mediated interactions of G protein-coupled receptors with postsynaptic density protein 95: quantitative characterization of interactions.Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways.Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stabilityThe 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks.Post-transcriptional regulation of opioid receptors in the nervous system.Protein-protein interactions at the adrenergic receptors.Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferationThe PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes.Beta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffoldCompartmentalization of beta-adrenergic signals in cardiomyocytes.Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines.Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases.Inhibition of the dopamine D1 receptor signaling by PSD-95.
P2860
Q24291900-5E39CB90-0465-4420-BBF6-14B97C1097F7Q24292697-190A5651-2F7B-400E-9DEC-EC37232B8378Q24293430-999F42EC-58A3-4E48-AD13-B31B7818D139Q24297397-36BD31FC-316B-461E-AE6B-0F0DB005FFAAQ24305154-9B752688-46C4-407C-9F9A-AE3CAC0581D5Q24311922-97228F22-D985-485F-A8EA-DC4EE5B1AF39Q28201893-EAA104D5-6C56-4E91-B551-A24904B48101Q28204363-355B61B1-2D5D-4DC0-B381-885FA938C364Q28205522-1119C3DD-3B10-4F12-B9ED-20CE25BA41DAQ28207676-D986F316-1615-4EC8-B99A-50F24176DDEBQ28216271-4E92BB86-94E5-4DFD-B451-7D22475063A4Q28217140-0E49FA6E-F236-4853-93D0-5830E13F48F3Q28511978-24108490-58DE-4E36-82C2-492B96558C65Q28565312-ABC09C11-C08D-4D6D-A05B-6C7B80060AB7Q28566984-E22936B1-D083-44F7-A5BA-E7342DAA7D93Q29616399-20F6EB98-3F32-446B-B51C-6021C2AC534FQ30009384-4CFC48CB-7714-4E8B-B7A5-112BD1F2BC22Q30009852-27087E79-6E6B-478E-8036-FAB94DB301E7Q30010478-41899F8A-4AFA-4A52-B46D-C41922E39DA5Q30494303-12DB5D40-EDD9-4855-BDC4-09A6C33D2A26Q33652136-F069BC1E-6F67-444A-BC29-6199EAA7BE08Q33678921-A731ECB8-FCE0-4C8E-9616-D1B351696AA4Q33730592-25919771-46ED-4849-8CC2-FF856CC77FC8Q33840022-5948DE95-AC3C-4DA8-84AB-289D2A8346D1Q34107365-4BDBE597-A5A4-4499-AB38-A2A51352B5D6Q34381331-C6BC7C8A-C75D-4737-B6B2-525827715EC0Q34672741-C2957D7C-5F78-45ED-A012-2D22DEFCE227Q34730310-6AFE7A65-10EB-41D0-A85A-6361CA11F746Q35044317-C1FE6701-E72C-44E4-9A34-FAB8991C46BDQ35128324-7BBBDE9D-EEBF-4BE1-AE09-A7D4DB6DE2B7Q35163938-BA71D591-31D4-4FB3-A2F7-7676F4EC07B0Q35672802-43E21493-2B6C-456A-8A5C-75B24B37971EQ35791490-6BEBDE7C-636D-477D-873D-F0796505D9AAQ35973795-764D694E-AB21-4575-85F1-835E696AFED2Q35978071-64FF6965-23E2-4D85-893B-965A992EB609Q36267511-48FDBD23-07A7-4E3E-8301-B783CCE3ECF4Q36384788-89C4BF56-C677-4734-A219-A9EB31FD9084Q36647344-6897C127-C451-425E-AE36-501F8F5F5052Q37068810-2627CB9C-59F5-421A-A028-D4E54935A58BQ37112269-1BEBF75C-3542-42DC-B267-7246874640FB
P2860
beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@ast
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@en
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@nl
type
label
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@ast
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@en
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@nl
prefLabel
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@ast
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@en
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@nl
P2093
P2860
P356
P1476
beta 1-adrenergic receptor ass ...... N-methyl-D-aspartate receptors
@en
P2093
P2860
P304
38659-38666
P356
10.1074/JBC.M005938200
P407
P577
2000-12-01T00:00:00Z